Correlating TCR diversity to immune reconstitution after cord blood transplant
Ended Project Grant Awarded Last action
- Award ID
- R44HL106868
- Recipient
-
Adaptive Biotechnologies Corporation UEI DMW5BNQ331K9
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,528,000
Award facts
- Assistance listing
- 93.839 Blood Diseases and Resources Research
- Completion date
- Originally
- Place of performance
- Seattle, WA 98102, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$467 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | -$774,822 | |
| Amendment | $774,822 | |
| Amendment | $519,759 | |
| Amendment | $1,057,509 | |
| Original award | $951,199 |
Quick answers
Who received award R44HL106868?
R44HL106868 was awarded to Adaptive Biotechnologies Corporation by National Heart Lung and Blood Institute (National Institutes of Health) on December 1, 2010.
How much is award R44HL106868 worth?
$2,528,000 has been obligated on R44HL106868.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award